Numan treatments

Could Wegovy protect your liver?

Wegovy, one of the weight loss medications that has recently made history in obesity management, has been shown to unexpectedly improve liver health. This is due to semaglutide, the active compound in Wegovy, which has demonstrated promising effects on liver enzymes and inflammation in people at risk of fatty liver disease.1

Switching from Mounjaro to Wegovy: expert advice from a Numan doctor

As you may be aware, Eli Lilly has announced a UK price increase on Mounjaro. We know changes like this can be unsettling. Our priority is safe, continuous care - keeping you informed, helping you weigh up your options, and supporting whatever decision you make.

Unlock weight loss: the power of health coaching

In the quest for a healthier life, maintaining a balanced weight is a cornerstone. But achieving sustainable weight loss is a challenge, marked by fad diets, conflicting advice, and a lack of personalised guidance. This is where health coaching comes in.

Your first month on Wegovy after Mounjaro: what to expect

Switching from one weight loss medication to another can feel daunting, especially if you’ve worked hard to make progress on Mounjaro. Many people worry that moving to Wegovy will undo their results or set them “back to square one.” However, with the right plan and support, you can protect your progress and keep building on the hard work you’ve already put in.

Oluchi’s journey: balancing motherhood, PCOS, and weight with Numan’s support

A few weeks ago, Oluchi joined us for a video shoot to share her story about managing her weight with two young children. Since then, we caught up with her for a follow-up interview to dive deeper into her experience with Numan’s Weight Loss Programme.

How and when to take Wegovy

Wegovy can be a powerful ally for weight loss, but its effectiveness hinges on correct usage. Here are 4 tips for how and when to take Wegovy

Top 5 myths about switching from Mounjaro to Wegovy

If you’ve been reading the news lately, you’ll know that switching from Mounjaro to Wegovy has sparked a lot of discussion. Some people are worried about side effects, others are anxious about losing progress, and plenty of myths are flying around about how the switch works.

How to switch from Mounjaro to Wegovy

Glucagon-like peptide-1 (GLP-1) receptor agonists are a type of medication recently approved for the treatment of weight loss.1 Though initially licensed for reducing blood sugar in individuals with type-2 diabetes, they also have the added benefits of slowing gastric emptying, reducing appetite, and aiding in weight loss, all of which contribute to better metabolic health

Higher dose of Wegovy tested in new obesity trial: what you need to know

A new study has explored whether a higher dose of the weight-loss injection semaglutide, better known by the brand name Wegovy, could help people with obesity lose more weight than currently marked doses.

The science behind switching: why some people might respond better to different weight loss medications

Weight loss treatments have transformed the way we treat obesity. Clinical trials show that people using these medications can lose anywhere between 16% and 21% of their body weight, depending on the drug and how well they stick with treatment.1,2 For many, that’s life-changing progress which leads to less breathlessness when walking upstairs, clothes that fit more comfortably, and improved health markers like blood pressure or blood sugar.1-3

How to stay on track during your switch from Mounjaro to Wegovy

Switching from one weight loss medication to another can feel a bit daunting. If you’re moving from Mounjaro to Wegovy, you might worry about setbacks, side effects, or whether your progress will stall.

Mounjaro, Wegovy, and Ozempic: what's the difference?

With the surge of attention around weight loss medications in the media, it's essential to cut through the noise and understand what sets Wegovy, Ozempic, and Mounjaro apart. Let's take a look into the specifics of these treatments.

Introducing our latest ad campaign with Ava: redefining the weight loss conversation

At Numan, we’re proud to be part of a transformation in how weight is discussed. Our new advert features Ava, a Numan patient who shares her story of navigating body image, her relationship with food, and the decision to use weight loss medication.